Follow the people · Insider
Talat Imran
Talat Imran files insider transactions with the SEC as a chief executive officer of Rani Therapeutics Holdings (RANI). We hold 2 disclosed purchases and sales filed since 13 September 2021, 2 of them in the last 90 days.
- Files forRANI
- Disclosed buys and sells2 in all, 2 in the last 90 days
- Last disclosure21 July 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 9 September 2021 — 17 July 2026Chief Executive Officer · Rani Therapeutics Holdings (RANI)33 Form 4 lines · source: SEC Form 4
Everything they disclosed
33 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 8,014 shares of Rani Therapeutics HoldingsSEC Form 421 July 2026Class A Common Stock · traded 27 December 2024 · filed 21 July 2026
- had shares withheld for tax on 9,076 shares of Rani Therapeutics HoldingsSEC Form 421 July 2026Class A Common Stock · traded 27 June 2025 · filed 21 July 2026
- had shares withheld for tax on 9,077 shares of Rani Therapeutics HoldingsSEC Form 421 July 2026Class A Common Stock · traded 27 September 2025 · filed 21 July 2026
- had shares withheld for tax on 7,906 shares of Rani Therapeutics HoldingsSEC Form 421 July 2026Class A Common Stock · traded 27 December 2025 · filed 21 July 2026
- had shares withheld for tax on 8,916 shares of Rani Therapeutics HoldingsSEC Form 421 July 2026Class A Common Stock · traded 22 March 2026 · filed 21 July 2026
- had shares withheld for tax on 9,099 shares of Rani Therapeutics HoldingsSEC Form 421 July 2026Class A Common Stock · traded 27 March 2026 · filed 21 July 2026
- had shares withheld for tax on 7,927 shares of Rani Therapeutics HoldingsSEC Form 421 July 2026Class A Common Stock · traded 27 June 2026 · filed 21 July 2026
- ▲ bought on the open market 35,000 shares of Rani Therapeutics HoldingsSEC Form 421 July 2026Class A Common Stock · traded 17 July 2026 · filed 21 July 2026
- was granted 3,800,000 shares of Rani Therapeutics Holdings (a derivative holding)SEC Form 45 June 2026Stock Option (Right to Buy) · traded 3 June 2026 · filed 5 June 2026
- was granted 1,053,000 shares of Rani Therapeutics Holdings (a derivative holding)SEC Form 423 May 2025Stock Option (Right to Buy) · traded 23 May 2025 · filed 23 May 2025
- ▲ bought on the open market 10,296 shares of Rani Therapeutics HoldingsSEC Form 410 December 2024Class A Common Stock · traded 9 December 2024 · filed 10 December 2024
- was granted 1,085,000 shares of Rani Therapeutics Holdings (a derivative holding)SEC Form 422 March 2024Stock Option (Right to Buy) · traded 21 March 2024 · filed 22 March 2024
- returned to the issuer 479,667 shares of Rani Therapeutics Holdings (a derivative holding)SEC Form 419 December 2023Stock Option (Right to Buy) · traded 16 December 2023 · filed 19 December 2023
- was granted 479,667 shares of Rani Therapeutics Holdings (a derivative holding)SEC Form 419 December 2023Stock Option (Right to Buy) · traded 16 December 2023 · filed 19 December 2023
- returned to the issuer 153,650 shares of Rani Therapeutics Holdings (a derivative holding)SEC Form 419 December 2023Stock Option (Right to Buy) · traded 16 December 2023 · filed 19 December 2023
- was granted 153,650 shares of Rani Therapeutics Holdings (a derivative holding)SEC Form 419 December 2023Stock Option (Right to Buy) · traded 16 December 2023 · filed 19 December 2023
- returned to the issuer 271,875 shares of Rani Therapeutics Holdings (a derivative holding)SEC Form 419 December 2023Stock Option (Right to Buy) · traded 16 December 2023 · filed 19 December 2023
- was granted 271,875 shares of Rani Therapeutics Holdings (a derivative holding)SEC Form 419 December 2023271875 · traded 16 December 2023 · filed 19 December 2023
- returned to the issuer 31,252 shares of Rani Therapeutics Holdings (a derivative holding)SEC Form 419 December 2023Stock Option (Right to Buy) · traded 16 December 2023 · filed 19 December 2023
- was granted 31,252 shares of Rani Therapeutics Holdings (a derivative holding)SEC Form 419 December 2023Stock Option (Right to Buy) · traded 16 December 2023 · filed 19 December 2023
- ▲ bought on the open market 10,000 shares of Rani Therapeutics HoldingsSEC Form 47 December 2023Class A Common Stock · traded 6 December 2023 · filed 7 December 2023
- ▲ bought on the open market 5,000 shares of Rani Therapeutics HoldingsSEC Form 46 December 2023Class A Common Stock · traded 4 December 2023 · filed 6 December 2023
- ▲ bought on the open market 20,000 shares of Rani Therapeutics HoldingsSEC Form 41 December 2023Class A Common Stock · traded 29 November 2023 · filed 1 December 2023
- ▲ bought on the open market 2,500 shares of Rani Therapeutics HoldingsSEC Form 49 November 2023Class A Common Stock · traded 7 November 2023 · filed 9 November 2023
- ▲ bought on the open market 2,500 shares of Rani Therapeutics HoldingsSEC Form 49 November 2023Class A Common Stock · traded 7 November 2023 · filed 9 November 2023
- was granted 575,600 shares of Rani Therapeutics Holdings (a derivative holding)SEC Form 429 March 2023Stock Option (Right to Buy) · traded 27 March 2023 · filed 29 March 2023
- was granted 353,500 shares of Rani Therapeutics HoldingsSEC Form 429 March 2023Class A Common Stock · traded 27 March 2023 · filed 29 March 2023
- had shares withheld for tax on 7,988 shares of Rani Therapeutics HoldingsSEC Form 424 March 2023Class A Common Stock · traded 22 March 2023 · filed 24 March 2023
- was granted 263,400 shares of Rani Therapeutics Holdings (a derivative holding)SEC Form 424 March 2022Stock Option (Right to Buy) · traded 22 March 2022 · filed 24 March 2022
- was granted 86,600 shares of Rani Therapeutics HoldingsSEC Form 424 March 2022Class A Common Stock · traded 22 March 2022 · filed 24 March 2022
- acquired or disposed of, other 827,467 shares of Rani Therapeutics HoldingsSEC Form 47 February 2022Class A Common Stock · traded 3 February 2022 · filed 7 February 2022
- acquired or disposed of, other 12,343 shares of Rani Therapeutics HoldingsSEC Form 47 February 2022Class A Common Stock · traded 3 February 2022 · filed 7 February 2022
- was granted 725,000 shares of Rani Therapeutics Holdings (a derivative holding)SEC Form 413 September 2021Stock Option (Right to Buy) · traded 9 September 2021 · filed 13 September 2021
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.